Seagen Inc - Company Profile
Powered by
All the data and insights you need on Seagen Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Seagen Inc Strategy Report
- Understand Seagen Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Seagen Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP4058024A1 | Application | VERFAHREN ZUR BEHANDLUNG VON HER2-POSITIVEM BRUSTKREBS MIT TUCATINIB IN KOMBINATION MIT EINEM ANTI-HER2-ANTIKÖRPER-WIRKSTOFF-KONJUGAT | A61K2039/505; A61K2039/545; A61K31/517; A61K39/39558; A61K45/06; A61K47/6803; A61K47/6855; A61P35/00; C07K16/32; C07K2317/77 | September 21, 2022 |
AU2022209203A1 | Application | Anti-NTB-A antibodies and related compositions and methods | A61K2039/505; A61K2039/572; A61K2121/00; A61K47/65; A61K47/6803; A61K47/6811; A61K47/6851; A61P35/00; C07K16/2803; C07K2317/24; C07K2317/33; C07K2317/567; C07K2317/73; C07K2317/732; C07K2317/92 | September 15, 2022 |
EP4054647A1 | Application | ANTI-CD30-ANTIKÖRPERMEDIKAMENT-KONJUGATE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON HIV-INFEKTIONEN | A61K39/39541; A61K45/06; A61K47/6803; A61K47/6849; A61P31/18; C07K16/2878; C07K2317/24; C07K2317/73 | September 14, 2022 |
AU2020281140B2 | Grant | Methylene carbamate linkers for use with targeted-drug conjugates | A61K47/60; A61K47/6803; A61K47/6863; A61K47/6889; A61P35/00; A61P37/06 | September 08, 2022 |
AU2021212193A1 | Application | Anti-CD30 antibody-drug conjugates and their use for the treatment of non-Hodgkin lymphoma | A61K2039/505; A61K2039/507; A61K2300/00; A61K31/454; A61K38/07; A61K38/08; A61K38/193; A61K47/6803; A61K47/6867; A61P35/00; A61P35/02; C07K16/2878; C07K16/2887; G01N2333/535; G01N2333/70578; G01N2333/70596; G01N33/57426 | September 08, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer